"Antithrombin III" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A plasma alpha 2 glycoprotein that accounts for the major antithrombin activity of normal plasma and also inhibits several other enzymes. It is a member of the serpin superfamily.
| Descriptor ID |
D000990
|
| MeSH Number(s) |
D12.644.861.060.500 D12.776.124.790.106.125 D12.776.377.715.085.125 D12.776.872.060.500 D23.113.025
|
| Concept/Terms |
Antithrombin III- Antithrombin III
- Heparin Co-Factor I
- Heparin Co Factor I
- Serpin C1
- Heparin Cofactor I
- Cofactor I, Heparin
|
Below are MeSH descriptors whose meaning is more general than "Antithrombin III".
Below are MeSH descriptors whose meaning is more specific than "Antithrombin III".
This graph shows the total number of publications written about "Antithrombin III" by people in this website by year, and whether "Antithrombin III" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
| 2006 | 1 | 1 | 2 |
| 2007 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antithrombin III" by people in Profiles.
-
Gupta A, Sarode R, Nagalla S. Thrombophilia Testing in Provoked Venous Thromboembolism: A Teachable Moment. JAMA Intern Med. 2017 08 01; 177(8):1195-1196.
-
Setty BN, Key NS, Rao AK, Gayen-Betal S, Krishnan S, Dampier CD, Stuart MJ. Tissue factor-positive monocytes in children with sickle cell disease: correlation with biomarkers of haemolysis. Br J Haematol. 2012 May; 157(3):370-80.
-
Nankervis CA, Preston TJ, Dysart KC, Wilkinson WD, Chicoine LG, Welty SE, Nelin LD. Assessing heparin dosing in neonates on venoarterial extracorporeal membrane oxygenation. ASAIO J. 2007 Jan-Feb; 53(1):111-4.
-
Gibson CM, Karmpaliotis D, Kosmidou I, Murphy SA, Kirtane AJ, Budiu D, Ray KK, Herrmann HC, Lakkis N, Kovach R, French W, Blankenship J, Lui HH, Palabrica T, Jennings LK, Cohen DJ, Morrow DA. Comparison of effects of bare metal versus drug-eluting stent implantation on biomarker levels following percutaneous coronary intervention for non-ST-elevation acute coronary syndrome. Am J Cardiol. 2006 May 15; 97(10):1473-7.
-
Minneci PC, Deans KJ, Cui X, Banks SM, Natanson C, Eichacker PQ. Antithrombotic therapies for sepsis: a need for more studies. Crit Care Med. 2006 Feb; 34(2):538-41.
-
Coleman MM, Spear ML, Finkelstein M, Leef KH, Pearlman SA, Chien C, Taylor SM, McKenzie SE. Short-term use of umbilical artery catheters may not be associated with increased risk for thrombosis. Pediatrics. 2004 Apr; 113(4):770-4.
-
De Cristofaro R, Landolfi R. Oxidation of human alpha-thrombin by the myeloperoxidase-H2O2-chloride system: structural and functional effects. Thromb Haemost. 2000 Feb; 83(2):253-61.
-
de Cristofaro R, de Candia E, Croce G, Morosetti R, Landolfi R. Binding of human alpha-thrombin to platelet GpIb: energetics and functional effects. Biochem J. 1998 Jun 15; 332 ( Pt 3):643-50.
-
Dryjski M, Kuo BS, Bjornsson TD. Interaction of thrombin and factor Xa with bovine vascular endothelial cells, smooth muscle cells and rat hepatoma cells. Thromb Haemost. 1988 Oct 31; 60(2):148-52.
-
Cocchetto DM, Bjornsson TD. Simulation: an underutilized approach to coagulation system model evaluation. Thromb Res. 1982 Oct 15; 28(2):223-36.